rs590086
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_054012.4(ASS1):c.495+1473C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.75 in 152,158 control chromosomes in the GnomAD database, including 48,300 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.75 ( 48300 hom., cov: 32)
Consequence
ASS1
NM_054012.4 intron
NM_054012.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.438
Publications
11 publications found
Genes affected
ASS1 (HGNC:758): (argininosuccinate synthase 1) The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of this gene cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2012]
ASS1 Gene-Disease associations (from GenCC):
- citrullinemia type IInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, G2P
- acute neonatal citrullinemia type IInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- adult-onset citrullinemia type IInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.974 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.751 AC: 114147AN: 152038Hom.: 48292 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
114147
AN:
152038
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.750 AC: 114183AN: 152158Hom.: 48300 Cov.: 32 AF XY: 0.759 AC XY: 56454AN XY: 74394 show subpopulations
GnomAD4 genome
AF:
AC:
114183
AN:
152158
Hom.:
Cov.:
32
AF XY:
AC XY:
56454
AN XY:
74394
show subpopulations
African (AFR)
AF:
AC:
13236
AN:
41428
American (AMR)
AF:
AC:
13313
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
3141
AN:
3472
East Asian (EAS)
AF:
AC:
5162
AN:
5178
South Asian (SAS)
AF:
AC:
4466
AN:
4826
European-Finnish (FIN)
AF:
AC:
10021
AN:
10612
Middle Eastern (MID)
AF:
AC:
241
AN:
294
European-Non Finnish (NFE)
AF:
AC:
62080
AN:
68030
Other (OTH)
AF:
AC:
1675
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
917
1834
2752
3669
4586
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
810
1620
2430
3240
4050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3135
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.